Answers are grounded in this paper and cite their sources.
Background Ayurveda, one of the oldest codified systems of individualized medicine, conceptualizes health through constitutional phenotyping ( Prakriti ), metabolic intelligence ( Agni ), tissue-level physiology ( Dhatu ), and dynamic disease states ( Vikriti ). Despite millennia of clinical application and population-scale practice, its integration with modern biomedical science has been hampered by the absence of standardized, objective, and reproducible molecular measurement frameworks. The emergence of multi-omics technologies, computational platforms, and artificial intelligence (AI) driven diagnostics now offers a scientifically rigorous pathway to investigate this integration and evaluate its potential as a framework for personalized medicine. Main body This narrative review, conducted and reported using the SANRA (Scale for the quality Assessment of Narrative Review Articles) framework as a quality assessment instrument, synthesizes published evidence from a focused database search covering publications from January 2008 to June 2025. Selected references outside the search were also included, ten of them issued after June 2025 and added during revision. It should be noted at the outset that the available evidence is predominantly cross-sectional and exploratory in nature; prospective clinical validation of biomarker-based constitutional medicine applications remains limited across all six Ayurvedic constructs reviewed. Four interconnected themes are addressed: the molecular and physiological candidate biomarker correlates of core Ayurvedic constructs, including genome-wide identification of 52 single-nucleotide polymorphisms associated with constitutional types in a single discovery cohort, without independent external replication to date, whole-genome expression profiling, epigenomic methylation analysis, gut-microbiome characterization, and biochemical and immunophenotypic profiling; technological advances encompassing AI-driven digitization of traditional diagnostics, Internet of Things (IoT)-enabled sensor platforms, digital preservation of classical scholarship, and computational infrastructure; the national and international institutional framework comprising the Ministry of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy), the Central Council for Research in Ayurvedic Sciences, and the World Health Organization (WHO) Global Centre for Traditional Medicine (WHO-GCTM); and persistent translational barriers including formulation standardization, assessment-tool fragmentation, underpowered trial designs, regulatory constraints, academic capacity deficits, and cost-effectiveness limitations, alongside evidence-grounded strategic solutions. Conclusion Multi-omics biomarker evidence provides preliminary biological support for candidate molecular correlates of Ayurvedic constitutional constructs, suggesting potential applications in constitutional risk stratification and targeted prevention. Pharmacogenomic applications remain an unresolved research hypothesis requiring prospective clinical validation. Realizing precision Ayurveda at clinical scale requires coordinated institutional commitment to standardization, adaptive trial design, regulatory innovation, dual-competency workforce development, and the development of affordable, scalable assessment tools compatible with Ayurveda’s population-level practice model.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: